Lundbeck Boosted by Ph3 Antidepressant Data - May 15, 2012

Having trouble viewing this email? View in Browser.

Tuesday, May 15, 2012  |   |   |   |  Reduce Risk and Maximize Potential in Ophthalmology Development Ophthalmic study design and execution can be quite different than other therapeutic areas. Pharm-Olam's team has a proven track record of excellence in achieving trial objectives and can provide strategic, operational and consulting to sponsors for phase I to phase IV development. The majority of our clinical staff in emerging markets are MDs or PhDs, including Ophthalmologists in strategic areas for clinical trials. The incidence of disorders and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning. Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121. •  Lundbeck Inc. (LUN.CO) Boosted by Ph3 Antidepressant Data More... •  Achillion Pharmaceuticals, Inc. (ACHN)'s Hepatitis C Drug Gets FDA Fast Track More... •  Cubist Pharmaceuticals, Inc. (CBST) Announces First Scientific Presentations of Phase 2 Data for CB-5945 in the Treatment of Opioid-Induced Constipation More... •  Achaogen Announces All Objectives Met in Phase 2 Plazomicin Complicated Urinary Tract Infections Study and Start of First-in-Human Study with ACHN-975 More... •  Helix Biopharma (CC:HBP) Commences Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47 More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News •  Hospira, Inc. (HSP) Recalls Pain Drug Cartridges More... More Discontinuations News More Recalls and Warning News •  TG Therapeutics, Inc. Announces Investigational New Drug (IND) for TGTX-1101, Receives Clearance by the FDA to Commence Clinical Trials in the U.S. More... More BLA/NDA/ANDA News More IND News More MAA News JAX® Patient-derived xenograft resource The enormous cost, and high failure rate, of cancer drug development have highlighted the need for new preclinical strategies and resources. To this end, a library of more diverse and representative patient-derived tumor xenograft (PDX) models has been created at The Jackson Laboratory. We utilize NOD scid IL2 receptor gamma chain knockout mice (NSG), constructed by JAX Professor Lenny Shultz, as the mouse host. This PDX resource (which includes tumor gene expression and copy number variation data), developed in collaboration with renowned medical centers throughout the United States, supports large-scale basic and preclinical cancer research and is both affordable and amenable to high throughput studies. For more information, please visitThe Jackson Laboratory. •  Touch Sensitivity is Genetically Linked to Hearing, Max Delbruck Center Study More... •  Brain Circuitry is Different for Women With Anorexia and Obesity, University of Colorado Study More... •  Playful Games Promote Reading Development, University of Gothenburg Study More... •  Pulmatrix Demonstrates iSPERSE Capabilities for Inhaled Dry Powder Delivery of Antibiotics and Antibodies More... •  Liquidia Technologies Inc. Studies Show PRINT® Engineered Particles Hold Promise in the Delivery of Respiratory Therapeutics More... More General Clinical Research News • BioMidwest (Boise, Iowa) Cubist Pharmaceuticals, Inc. Clinical Business Manager Possesses deep customer knowledge and understands the hospital marketplace and the goals and concerns of each targeted hospital within their defined territory (patient care issues, protocols, reimbursement).Is able to create and implement a business strategy based on the marketplace dynamics. • Genetown (Billerica, Massachusetts) PAREXEL International Clinical Logistics Leader Ensures that clinical logistics projects are progressing and systems are set up and maintained according to quality standards, SOPs and applicable ICH-GxP* and other applicable industry guidelines. • Biotech Bay (Redwood City, California) Abbott Senior Section Manager, Clinical Data Management ensures that a) CRFs or eCRFs, clinical databases and clinical data management plans are prepared and approved within project timelines and b) applicable project and global data management standards are applied. • Biotech Beach (Irvine, California) Spectrum Pharmaceuticals, Inc. Clinical Trial Manager Manages overall operational implementation of the clinical project to execute on the study and scientific plan and ensure overall quality over the life of a study. Develops study specific tools and documents, and provides overall direction for the clinical sites and to study team members. • Bio NC (Raleigh, North Carolina) EnteraHealth Director of Clinical Research Lead and manage all aspects of Clinical Trial(s) including working relationships, budgets, execution and performance of Clinical Trial Team(s). Manages and directs the design, implementation and monitoring of clinical trials. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! Biotech Bay Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Bay area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Biotech Bay Career Fair, Burlingame, CA May 29, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  New US Patent Grant for ValiRx Plc's Cancer Screening Gene Biomarker More... More Patent News •  How Payers View Pfizer Inc. (PFE)'s Rheumatoid Arthritis Pill More... •  U.S. FDA Approves Bristol-Myers Squibb Company (BMY) Devens Biologics Manufacturing Facility for Production of ORENCIA® (abatacept) More... More Drug Product News Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! Biomarkers in Late Stage Clinical Trials • Quantify and analyze revenues of late stage biomarker technology and services in North America, Europe, Asia and the Rest of the World. • Identify the key market drivers and resistors of the biomarker market and evaluate the growth potential of emerging technologies. • Assess biomarker activity at leading companies, including Abbott, AZ, BMS, Eli Lilly, GSK, Merck & Co, Novartis, Pfizer, Roche and Sanofi-Aventis. Click Here for More Information. Hot Company High Point Clinical Trials Center 4160 Mendenhall Oaks Parkway, Suite 105 High Point, North Carolina 27265 U.S.A. Phone: 877-296-1444 High Point Clinical Trials Center is committed to the safe and ethical conduct of clinical trials for investigational drugs in a pleasant, comfortable environment for research participants. More Company Profiles Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.